Across TCGA pan-cancer cohorts, LIN54 Mutation is linked to patient survival in 3 of 34 cancer types, making it a survival-associated LIN54 data layer compared with 22 for mass-spec protein and 4 for mass-spec protein.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher LIN54 Mutation is associated with better disease-free survival. In most high-consensus cancer types, elevated LIN54 expression acts as an unfavorable survival marker, although some lineages such as UCEC show a favorable association.

UCEC, BLCA, and ESCA are the cancer types where LIN54 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	DFS	Median	All	0.933	0.623	.019	20	view →
BLCA	DFS	Median	III,IV	0.146	0.574	.002	15	view →
ESCA	OS	Median	II,III,IV	0.216	0.702	.014	6	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

Exploration

Same gene, other analysis: LIN54 tumor-vs-normal RNA expression · all LIN54 data types